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Abstract:  Bidirectional  signaling  between  Eph  receptor  tyrosine  kinases  and  their  
cell-surface protein signals, the ephrins, comprises one mechanism for guiding motor axons 
to their proper targets. During projection of motor axons from the lateral motor column 
(LMC)  motor  neurons  of  the  spinal  cord  to  the  hindlimb  muscles  in  chick  embryos,  
ephrin-A5 has been shown to be expressed in the LMC motor axons until they reach the 
base of the limb bud and initiate sorting into their presumptive dorsal and ventral nerve 
trunks,  at  which  point  expression  is  extinguished.  We  tested  the  hypothesis  that  this 
dynamic pattern of ephrin-A5 expression in LMC motor axons is important for the growth 
and  guidance  of  the  axons  to,  and  into,  the  hindlimb  by  knocking  down  endogenous  
ephrin-A5 expression in the motor neurons and their axons. No perturbation of LMC motor 
axon projections was observed in response to this treatment, suggesting that ephrin-A5 is 
not needed for LMC motor axon growth or guidance. 
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1. Introduction 
Proper muscle function requires that muscles be innervated by appropriate motor neurons and their 
axons  from  the  central  nervous  system.  One  mechanism  for  guiding  motor  axons  to  their  correct 
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destination involves bidirectional signaling between the Eph family of receptor tyrosine kinases and 
their cell-surface protein signals, the ephrins (reviewed in [1]). Contact between a cell expressing Ephs 
and a cell expressing ephrins has been shown to cause repulsion between the two cells. Motor axons 
expressing  Ephs,  therefore,  are  thought  to  be  guided  to  the  appropriate  destination  by  having  all 
inappropriate tissues express ephrins and ensuring the appropriate tissues do not express ephrins.  
An example of this system is seen in the motor axons projecting from the lateral motor column of 
the spinal cord. The lateral motor column (LMC) forms at the level of the limbs and the positions of 
motor neurons in the LMC predicts which limb muscles they will innervate. Motor neurons and their 
axons in the lateral portion of the LMC project to dorsal limb muscles, whereas motor neurons in the 
medial portion project to ventral limb muscles [2]. It has been shown that one member of the Eph 
family, EphA4, is expressed only in lateral LMC motor neurons, and ephrin-A5, a member of the 
ephrin family of signal proteins, has its expression in ventral hindlimb mesoderm (into which muscle 
precursor cells migrate and develop into the ventral hindlimb muscles) [3]. Ephrin-A2 is expressed in 
both lateral and medial LMC motor neurons and their axons (Figure 1). There is no expression of 
EphAs in medial LMC neurons, nor is there expression of ephrin-As in dorsal mesoderm at this time 
(stage 28) [4]. Thus, lateral motor neurons of the LMC are thought to extend their motor axons only 
into dorsal mesoderm; these motor axons are repelled by the ephrin-A5-expressing ventral mesoderm. 
Medial  motor  neurons  in  the  LMC  are  thought  to  extend  their  motor  axons  into  the  ephrin-A5 
expressing ventral mesoderm, because the motor axons are thought to express no EphAs and aren’t 
repelled (Figure 1). 
Complicating this scheme is the observation that, during their growth and initial migration out of 
the spinal cord, all axons of the LMC express ephrin-A5 (Figure 1) [5]. When the axons reach the base 
of  the  hindlimb  and  initiate  sorting  into  their  presumptive  dorsal  and  ventral  nerve  trunks,  this 
expression ceases. A summary of the expression patterns of EphA4, ephrin-A2, and ephrin-A5 on 
hindlimb  motor  axons  is  shown  in  Figure  1.  Such  a  dynamic  pattern  of  expression  suggests  that  
ephrin-A5 expression in the motor neurons and their axons may play a role in guiding the growth or 
migration of axons from the LMC prior to branching at the base of the limb bud, and/or in the limb  
bud after branching. Ephrin-A5 could affect growth or migration either via its receptor function, 
signaling  back  to  its  expressing  cell,  or  through  its  ligand  function,  by  binding  to  EphA4  on  
the  surface  of  axons  in  the  same  tract,  or  both.  We  have  tested  this  hypothesis  by  using  an  
shRNA approach to knock down normal ephrin-A5 expression in LMC axons exiting the spinal cord. 
Our  results  show  that  this  loss-of-function  approach  resulted  in  no  motor  axonal  growth  or  
migration defects. Int. J. Mol. Sci. 2011, 12                       
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Figure 1. Expression of EphA4, ephrin-A5, and ephrin-A2 during motor axon projections 
to the chick hindlimb. 
 
2. Results and Discussion  
Various constructs encoding ephrin-A5 shRNAs were transfected into chick neural tubes and tested 
for their ability to knock down ephrin-A5 expression 24 h post-transfection at stage 21; the results for 
one of these shRNAs (designated “236”) is shown in Figure 2. The GFP protein (green; driven by the 
chick beta-actin promotor and CMV enhancer) is from motor neurons transfected with either pCAX 
(controls), co-transfected with pCAX and shRNA against ephrin-A5 (236 shRNA), or co-transfected 
with pCAX and a mutated version of 236 shRNA (236 M shRNA). Stage 21 was chosen because it is a 
point prior to the natural down-regulation of ephrin-A5 by stage 23. For any ephrin-A5 knockdown  
to have an effect on LMC motor axons, it would have to be achieved while ephrin-A5 is still expressed 
in the LMC motor neurons, prior to or at stage 23. GFP expression indicates which cells/tissues have 
been transfected (Figure 2A,C,E). Expression of ephrin-A5 (Figure 2B,D,F) was observed throughout Int. J. Mol. Sci. 2011, 12                       
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most of the neural tube, although there were areas of higher signal intensity, particularly in a horizontal 
stripe across the center of the neural tube, and in the motor columns. Looking at these areas, neural tubes 
transfected with plasmid encoding pCAX and 236 shRNA (against ephin-A5) showed decreased ephrin-
A5 signal (Figure 2D) compared to control embryos (Figure 2B). In contrast, neural tubes transfected 
with plasmid encoding 236 M shRNA (a mutated form of 236 shRNA) exhibited no such decrease in 
ephrin-A5 (Figure 2F; see Experimental Section).  
Figure  2.  Knockdown  of  ephrin-A5  expression  by  236  shRNA.  Chick  embryos  were  
co-transfected at stage  15/16 with pCAX alone (A,B), pCAX and 236 shRNA, against 
ephrin-A5 (C,D), or pCAX and 236 M shRNA, a mutated form of 236 (E,F). Vibratome 
sections of embryos fixed at stage 21 were stained with antibody against ephrin-A5 and 
examined for GFP expression (A,C,E) or antibody staining (B,D,F).  
 
To assess the effectiveness of 236 shRNA, signal intensity on the transfected side of the neural  
tube was quantified using Image Gauge software (Fuji) and compared with signal intensity on the  
non-transfected side of the neural tube. Readings were taken at three spots on each side of the neural Int. J. Mol. Sci. 2011, 12                       
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tube (two within the horizontal stripe and one within the motor column), the readings for the three 
spots (less background) were averaged, and the percent difference between the transfected side and  
the  non-transfected  side  was  calculated.  The  results  are  shown  in  Table  1.  Embryos  expressing  
236 shRNA exhibited an ephrin-A5 signal intensity on the transfected side of the neural tube that was 
an average of more than 40% lower than on the non-transfected side of the neural tube. In contrast, 
control embryos (those expressing pCAX alone or pCAX with a mutated shRNA, 236 M) exhibited 
little difference between the two sides of the neural tube. These data suggest that 236 shRNA was 
effective at knocking down ephrin-A5 expression by approximately 40%, whereas 236 M shRNA was 
apparently  ineffective.  Three  other  shRNA  constructs  (targeting  ephrin-A5  mRNA  beginning  at 
positions 248, 373, and 571, respectively) were also tested, but none was shown to be as effective as 
236 shRNA at knocking down ephrin-A5 (data not shown). As a result, subsequent experiments were 
done using the 236 shRNA plasmid. 
Table 1. Percentage decrease in ephrin-A5 expression in the transfected side of the neural 
tube compared to the non-transfected side after in ovo electroporation with control plasmids 
or plasmid encoding ephrin-A5 shRNA. 
Sample  pCAX only 
Ephrin-A5 shRNA 
(236) + pCAX 
Control shRNA 
(236 M) + pCAX 
Number of 
embryos observed 
8  9  7 
Ephrin-A5 
expression 
difference 
0.45 ± 19.1%  40.42 ± 10.75%  1.62 ± 9.33% 
To assess the effect of the 236 shRNA on growth or early migration of axons from the LMC, 
controls and embryos transfected with plasmid encoding 236 shRNA were allowed to develop to stage 
26, at which time embryos were fixed, sectioned and stained with antibodies against neurofilaments 
(Invitrogen; see Experimental Section). The results are presented in Figure 3. For these experiments, 
embryos were co-transfected with a plasmid encoding GFP under the control of the HB9 promoter, 
which is active only in motor neurons and their axons [6]. Three consecutive sections from representative 
control (Figure 3A–F; n = 6) and ephrin-A5 shRNA-transfected embryos (Figure 3G–L; n = 8) are 
presented,  with  both  GFP  (Figure  3A,C,E,G,I,K)  and  neurofilament  staining  (Figure  3B,D,F,H,J,L) 
shown for each section. GFP expression was strong in the LMC on the transfected side of the neural 
tubes of both control and experimental embryos, and was visible in the motor axons emanating from 
the LMC, confirming expression of the transfected genes in LMC neuronal cell bodies and axons. 
Comparison of axonal growth or migration between the two groups revealed no obvious difference 
between the two groups. LMC axons branched normally at the base of the limb bud in both groups (in 
particular,  see  Figure  3C/D,I/J),  and  extended  correctly  into  the  limb  mesoderm  (Figure  3E/F;  
Figure 3I/J,K/L). This suggests that migration of LMC axons is unperturbed by an approximate 40% 
reduction in ephrin-A5 expression in the neurons.  Int. J. Mol. Sci. 2011, 12                       
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Figure  3.  Effect  of  ephrin-A5  shRNA  on  LMC  axon  growth  and  migration.  Embryos  
were  co-transfected  at  stage  15/16  with  HB9  and  236  M  (control;  A–F)  or  HB9  and  
236 (ephrin-A5 shRNA; G–L) and fixed at stage 26. Vibratome sections were stained with 
anti-neurofilament antibody (NF) and examined for GFP fluorescence (A,C,E;G,I,K) and 
antibody staining (B,D,F;H,J,L). Note: motor axons have extended into the limb at stage 
26 in A,B but are omitted here. 
 
Despite the apparently normal projection of LMC axons, it was possible that cell bodies within the 
LMC  sorted  incorrectly  or  were  disrupted  in  some  manner.  To  examine  this  possibility,  embryo 
sections were stained with antibody against islet-1 (isl-1; DSHB), which is initially expressed in all Int. J. Mol. Sci. 2011, 12                       
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cells  of  the  LMC,  but  subsequently  becomes  restricted  to  the  medial  LMC  [7].  Sections  from 
representative control (n = 6) and ephrin-A5 shRNA-expressing embryos are shown in Figure 4. GFP 
expression  was  strong  in  the  LMC  on  the  transfected  side  of  the  neural  tube  in  both  groups 
(Figure 4A,C), indicating expression of the transfected genes in the LMC and their axons. In both the 
control  and  experimental  groups,  isl-1  staining  was  observed  throughout  the  LMC  (Figure  4B,D), 
although expression was stronger in the medial LMC in both groups (particularly cogent in Figure 4D). 
These  results  suggest  that  isl-1-expressing  neurons  were  sorting  correctly  within  the  LMC  in  the 
ephrin-A5 knockdown embryos. 
Figure  4.  Effect  of  ephrin-A5  shRNA  on  islet-1  (isl-1)  expression.  Embryos  were  
co-transfected  at  stage  15/16  with  HB9  and  236  M  (Control;  A,B)  or  with  HB9  and  
236  shRNA  (against  ephrin-A5;  C,D)  and  fixed  at  stage  26.  Vibratome  sections  were 
stained with antibody against isl-1 and examined for GFP fluorescence (A,C) and antibody 
staining (B, D).  
 
3. Experimental Section 
3.1. Ephrin-A5 shRNA Constructs 
The chicken ephrin-A5 cDNA sequence was entered into Ambion’s siRNA Target Finder algorithm 
to  identify  potential  shRNA  sequences.  Candidate  21-mer  sequences  were  entered  into  a  BLAST 
search to ensure no non-specific interactions with genes other than ephrin-A5. Four sequences were 
chosen, and shRNA sequences were devised using Ambion’s template design tool. Oligonucleotides 
comprising both strands of these sequences were synthesized by Invitrogen, annealed, and ligated into Int. J. Mol. Sci. 2011, 12                       
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the Bam HI site of the pSilencer 1.0 vector (Ambion), in which shRNA transcription is driven by a U6 
promoter. All plasmid constructs were sequenced by the University of Michigan sequencing core to 
confirm fidelity of the shRNA-encoding sequences in the vectors. The various shRNA constructs were 
tested by transfection into chick neural tubes at stage 15/16 using in ovo electroporation as described 
below,  allowing  the  embryos  to  develop  to  stage  21,  and  assessing  the  expression  of  ephrin-A5. 
Ephrin-A5  expression  was  assayed  by  staining  embryo  sections  with  anti-ephrin-A5  antibody  as 
described below, followed by comparison of expression on the transfected side to that on the non-
transfected side (for details, see “Immunohistochemistry”, below). The shRNA that achieved the best 
knockdown (approximately 40% reduction in ephrin-A5 expression; see Table 1) was used for all 
subsequent  experiments.  This  construct,  dubbed  “236  shRNA”  targeted  a  sequence  beginning  at 
position  236  of  chick  ephrin-A5  mRNA  (5′-AAGAUAAGACCGAACGCUAUG-3′).  A  mutated 
version of this sequence was devised by swapping positions of 4 bases within the sequence, producing 
a construct called “236 M shRNA”. 
3.2. In Ovo Electroporation 
Fertilized White Leghorn chicken eggs (MSU Poultry Farm) were incubated at 37 °C until stage  
15–16 [8], windowed, and subjected to dorsoventral in ovo electroporation (targeting a ventral quadrant 
of the neural tube) according to procedures described previously [3,9,10]. Pulled glass micropipettes 
were used to introduce plasmid DNA [typically a mixture of an shRNA-encoding construct at 3–5 µg/µL 
and either pCAX [9] at 0.1 µg/µL or HB9-GFP [6] at 2–4 µg/µL into the neural tube, and four 15 V 
pulses  of  50  ms  duration  each  were  delivered  through  home-made  platinum  electrodes.  After 
electroporation, embryos were bathed in a small amount of sterile Ringer’s solution, resealed with 
parafilm, and incubated until reaching the desired stage.  
3.3. Immunohistochemistry 
Embryos were harvested at the desired stage and fixed overnight at 4 °C in 4% paraformaldehyde. 
After washing in 1X PBS, embryos were eviscerated, and the dorsal body wall and hindlimbs isolated 
and  embedded  in  6%  low  melting  point  (LMP)  agarose  (Sigma).  100  µm  vibratome  sections  were 
prepared and stained with antibody against ephrin-A5 [4], mouse neurofilament (NF-M; Invitrogen), or 
islet-1  (DSHB),  as  described  previously  [3].  Appropriate  Alexa  Fluor  568  secondary  antibodies 
(Invitrogen) were used to detect primary antibody binding. Antibody signal intensities were quantified 
using Image Gauge software (Fuji). Measurements were taken at three points each on the transfected 
side and the non-transfected side of each embryo, background subtracted, and comparisons were made 
between the two sides of the embryo. 
4. Conclusions  
Our results indicate that perturbation of normal ephrin-A5 expression in LMC motor neurons and 
their axons with specific shRNAs against ephrin-A5 had no effect on the growth or migration of the 
motor axons. Knockdown of ephrin-A5 expression using an shRNA approach did not alter the growth or 
migration of motor axons into the hindlimb, nor did it appear to affect sorting of the cell bodies in the Int. J. Mol. Sci. 2011, 12                       
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LMC. Therefore, it may be that the dynamic expression pattern of ephrin-A5 is of little importance to the 
growth or guidance of migrating LMC axons; however, there are two possible alternative explanations.  
First, it may be that ephrin-A5 expression in axons exiting the spinal cord does play a role in  
growth or guiding migration, but that 40% knockdown of its expression is insufficient to disrupt its 
function. Testing additional shRNA sequences may yield one that knocks down expression by a greater 
amount, although it may be that the timing of developmental events makes ephrin-A5 in LMC axons 
refractory to an shRNA approach. Electroporation was performed at stage 15/16 to apply the DNA to 
LMC precursors. Endogenous expression of ephrin-A5 ceases by about stage 23 [5], which occurs 
approximately 30 h beyond stage 15/16. This leaves a very narrow window in which to knock down 
ephrin-A5, and it is conceivable that a more robust knockdown of ephrin-A5 is not achievable within 
this timeframe. 
Second,  redundancy  may  have  prevented  our  discerning  a  developmental  role  for  ephrin-A5 
expression in LMC axons. Ephrin-A2 is also expressed in LMC axons migrating out of the spinal  
cord, and this expression persists after ephrin-A5 expression is no longer detectable [4]. It is possible 
that  persistent  ephrin-A2  may  be  able  to  functionally  replace  the  lost  ephrin-A5  signaling  in  236 
shRNA-transfected embryos. If that is the case, it may require a double knockdown of ephrin-A5 and 
ephrin-A2 in order to observe disruption of growth or the normal migration pattern of LMC axons. 
Taken all together, it is surprising that altering ephin-A5 function has no effect on motor axon 
growth or guidance to the hindlimb, using a loss-of-function approach. Perhaps ephrin-A5 contributes 
in some unknown manner to spontaneous activity [6]. Further electrophysiological experiments will be 
required to uncover the role of ephrin-A5 in motor axon growth and guidance to the hindlimb. 
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